Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis
Authors:
Top Cited Papers
Open Access
- 10 February 2022
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (7) , 920-927
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Northern Alberta Clinical Trials and Research Centre
This publication has 21 references indexed in Scilit:
- Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort studyClinical Microbiology and Infection, 2021
- Surveillance for COVID-19-associated pulmonary aspergillosisThe Lancet Microbe, 2020
- COVID-19–associated Pulmonary AspergillosisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19The Lancet Respiratory Medicine, 2020
- Diagnosing COVID-19-associated pulmonary aspergillosisThe Lancet Microbe, 2020
- Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inactionBMJ, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012